Evercore ISI Group Maintains Outperform on Inspire Medical Systems, Lowers Price Target to $62

Benzinga Newsdesk www.benzinga.com Negative 95.4%

Neg 95.4% Neu 0% Pos 0%

Evercore ISI Group analyst Daniel Markowitz maintains Inspire Medical Systems (NYSE:INSP) with a Outperform and lowers the price target from $85 to $62.